Asdera

We plan a phase 3 trial to get FDA-approval for a drug (pat. pending) to prevent children developing autism from becoming non-verbal (life-long disability).

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location New York, NY, US
  • Currency USD
  • Founded September 2013
  • Employees 1
  • Incorporation Type LLC
  • Website asdera.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free